MTOR and cancer: A growing body of evidence indicates that 4E-BP1 is a critical effector of mTOR signaling through translational control of key oncogenic mRNAs that encode proteins for cell-cycle progression, cell survival, angiogenesis, cancer progression, and metastasis17.